These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24715496)

  • 1. Construction of a live-attenuated HIV-1 vaccine through genetic code expansion.
    Wang N; Li Y; Niu W; Sun M; Cerny R; Li Q; Guo J
    Angew Chem Int Ed Engl; 2014 May; 53(19):4867-71. PubMed ID: 24715496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling Multicycle Replication of Live-Attenuated HIV-1 Using an Unnatural Genetic Switch.
    Yuan Z; Wang N; Kang G; Niu W; Li Q; Guo J
    ACS Synth Biol; 2017 Apr; 6(4):721-731. PubMed ID: 28106981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.
    Das AT; Zhou X; Vink M; Klaver B; Berkhout B
    Expert Rev Vaccines; 2002 Oct; 1(3):293-301. PubMed ID: 12901570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains.
    Berkhout B; Verhoef K; van Wamel JL; Back NK
    J Virol; 1999 Feb; 73(2):1138-45. PubMed ID: 9882315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-defective HIV as a vaccine candidate.
    Tung FY; Rinaldo CR; Montelaro RC
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1247-52. PubMed ID: 9764908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel non-integrative single-cycle chimeric HIV lentivector DNA vaccine.
    Moussa M; Arrode-Brusés G; Manoylov I; Malogolovkin A; Mompelat D; Ishimwe H; Smaoune A; Ouzrout B; Gagnon J; Chebloune Y
    Vaccine; 2015 May; 33(19):2273-2282. PubMed ID: 25825333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies.
    Marzio G; Verhoef K; Vink M; Berkhout B
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6342-7. PubMed ID: 11353837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on virulence of HIV and development of non-virulent live AIDS vaccine using monkeys].
    Hayami M; Horiuchi R
    Uirusu; 2004 Jun; 54(1):75-82. PubMed ID: 15449907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated AIDS viruses as vaccines: promise or peril?
    Ruprecht RM
    Immunol Rev; 1999 Aug; 170():135-49. PubMed ID: 10566148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
    Stephenson KE; Keefer MC; Bunce CA; Frances D; Abbink P; Maxfield LF; Neubauer GH; Nkolola J; Peter L; Lane C; Park H; Verlinde C; Lombardo A; Yallop C; Havenga M; Fast P; Treanor J; Barouch DH
    PLoS One; 2018; 13(11):e0205139. PubMed ID: 30427829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions.
    Virnik K; Ni Y; Berkower I
    Vaccine; 2013 Apr; 31(17):2119-25. PubMed ID: 23474312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
    van Diepen MT; Chapman R; Douglass N; Galant S; Moore PL; Margolin E; Ximba P; Morris L; Rybicki EP; Williamson AL
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30760570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killed whole-HIV vaccine; employing a well established strategy for antiviral vaccines.
    Kang CY; Gao Y
    AIDS Res Ther; 2017 Sep; 14(1):47. PubMed ID: 28893272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic stability of a conditional live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution.
    Zhou X; Vink M; Klaver B; Verhoef K; Marzio G; Das AT; Berkhout B
    J Biol Chem; 2006 Jun; 281(25):17084-17091. PubMed ID: 16627480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine.
    Smith SM; Khoroshev M; Marx PA; Orenstein J; Jeang KT
    J Biol Chem; 2001 Aug; 276(34):32184-90. PubMed ID: 11397795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV with multiple gene deletions as a live attenuated vaccine for AIDS.
    Desrosiers RC
    AIDS Res Hum Retroviruses; 1992 Mar; 8(3):411-21. PubMed ID: 1571200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
    Clarke DK; Hendry RM; Singh V; Rose JK; Seligman SJ; Klug B; Kochhar S; Mac LM; Carbery B; Chen RT;
    Vaccine; 2016 Dec; 34(51):6597-6609. PubMed ID: 27395563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.
    Berkhout B; Verhoef K; Marzio G; Klaver B; Vink M; Zhou X; Das AT
    J Neurovirol; 2002 Dec; 8 Suppl 2():134-7. PubMed ID: 12491165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
    Kim BJ; Kim BR; Kook YH; Kim BJ
    Front Immunol; 2018; 9():643. PubMed ID: 29636755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particle-based vaccines for HIV-1 infection.
    Young KR; Ross TM
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):151-69. PubMed ID: 12769792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.